Mu-Opioid Receptor Agonists Differentially Regulate the Expression of MiR-190 and NeuroD

Overview

Journal Mol Pharmacol

Specialties Molecular Biology
Pharmacology

Date 2009 Oct 27

PMID 19854889

Citations 66

Authors

Hui Zheng

Yan Zeng

Xiaoxiao Zhang

Ji Chu

Horace H Loh

Ping-Yee Law

Affiliations

Soon will be listed here.

Abstract

The agonists of mu-opioid receptor (OPRM1) induce extracellular signal-regulated kinase (ERK) phosphorylation through different pathways: morphine uses the protein kinase C (PKC)-pathway, whereas fentanyl functions in a beta-arrestin2-dependent manner. In addition, the two pathways result in the different cellular location of phosphorylated ERK and the activation of different sets of transcriptional factors. In the current study, the influence of the two pathways on the expression of microRNAs (miRNAs) was investigated. After treating the primary culture of rat hippocampal neurons and the mouse hippocampi with morphine or fentanyl for 3 days, seven miRNAs regulated by one or two of the agonists were identified. One of the identified miRNAs, miR-190, was down-regulated by fentanyl but not by morphine. This down-regulation was attenuated by 1,4-diamino-2,3-dicyano-1,4-bis(methylthio)butadiene (U0126), which blocks the phosphorylation of ERK. When fentanyl-induced but not morphine-induced ERK phosphorylation was blocked in the primary cultures from beta-arrestin2(-/-) mouse, fentanyl did not decrease the expression of miR-190. However, a PKC inhibitor that blocked morphine-induced ERK phosphorylation specifically had no effect on the miR-190 down-regulation. Therefore the decrease in miR-190 expression resulted from the agonist-selective ERK phosphorylation. In addition, the expressional changes in one of the miR-190 targets, neurogenic differentiation 1 (NeuroD), correlated with those in miR-190 expression, suggesting the OPRM1 could regulate the NeuroD pathways via the control of miR-190 expression.

Citing Articles

Epigenetic regulation in opioid induced hyperalgesia.

Reddy D, Wickman J, Ajit S Neurobiol Pain. 2023; 14:100146.

PMID: 38099284 PMC: 10719581. DOI: 10.1016/j.ynpai.2023.100146.

miRNAs and Substances Abuse: Clinical and Forensic Pathological Implications: A Systematic Review.

Occhipinti C, La Russa R, Iacoponi N, Lazzari J, Costantino A, Di Fazio N Int J Mol Sci. 2023; 24(23).

PMID: 38069445 PMC: 10707252. DOI: 10.3390/ijms242317122.

Functional genomic mechanisms of opioid action and opioid use disorder: a systematic review of animal models and human studies.

Falconnier C, Caparros-Roissard A, Decraene C, Lutz P Mol Psychiatry. 2023; 28(11):4568-4584.

PMID: 37723284 PMC: 10914629. DOI: 10.1038/s41380-023-02238-1.

MiR-33-5p Regulates CREB to Induce Morphine State-dependent Memory in Rats: Interaction with the µ Opioid Receptor.

Vastegani S, Alani B, Kharazmi K, Ardjmand A Int J Mol Cell Med. 2023; 11(2):150-167.

PMID: 37091037 PMC: 10116354. DOI: 10.22088/IJMCM.BUMS.11.2.150.

Mechanisms Underlying Mu Opioid Receptor Effects on Parallel Fiber-Purkinje Cell Synaptic Transmission in Mouse Cerebellar Cortex.

Yang Y, Bai J, Sun J, Ye T, Zhang L, Wu F Front Synaptic Neurosci. 2022; 14:862704.

PMID: 35546898 PMC: 9083459. DOI: 10.3389/fnsyn.2022.862704.

References

Shenoy S, Drake M, Nelson C, Houtz D, Xiao K, Madabushi S . beta-arrestin-dependent, G protein-independent ERK1/2 activation by the beta2 adrenergic receptor. J Biol Chem. 2005; 281(2):1261-73. DOI: 10.1074/jbc.M506576200. View

Nam J, Ino Y, Sakamoto M, Hirohashi S . Src family kinase inhibitor PP2 restores the E-cadherin/catenin cell adhesion system in human cancer cells and reduces cancer metastasis. Clin Cancer Res. 2002; 8(7):2430-6. View

Favata M, Horiuchi K, Manos E, Daulerio A, Stradley D, Feeser W . Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J Biol Chem. 1998; 273(29):18623-32. DOI: 10.1074/jbc.273.29.18623. View

Kalscheuer S, Zhang X, Zeng Y, Upadhyaya P . Differential expression of microRNAs in early-stage neoplastic transformation in the lungs of F344 rats chronically treated with the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Carcinogenesis. 2008; 29(12):2394-9. PMC: 2722864. DOI: 10.1093/carcin/bgn209. View

Ma L, Pei G . Beta-arrestin signaling and regulation of transcription. J Cell Sci. 2007; 120(Pt 2):213-8. DOI: 10.1242/jcs.03338. View

Muid R, DALE M, Davis P, ELLIOTT L, Hill C, Kumar H . A novel conformationally restricted protein kinase C inhibitor, Ro 31-8425, inhibits human neutrophil superoxide generation by soluble, particulate and post-receptor stimuli. FEBS Lett. 1991; 293(1-2):169-72. DOI: 10.1016/0014-5793(91)81178-b. View

Duttaroy A, Yoburn B . The effect of intrinsic efficacy on opioid tolerance. Anesthesiology. 1995; 82(5):1226-36. DOI: 10.1097/00000542-199505000-00018. View

Jin W, Lo T, Loh H, Thayer S . U73122 inhibits phospholipase C-dependent calcium mobilization in neuronal cells. Brain Res. 1994; 642(1-2):237-43. DOI: 10.1016/0006-8993(94)90927-x. View

Seo S, Lim J, Yellajoshyula D, Chang L, Kroll K . Neurogenin and NeuroD direct transcriptional targets and their regulatory enhancers. EMBO J. 2007; 26(24):5093-108. PMC: 2140110. DOI: 10.1038/sj.emboj.7601923. View

10.

DeWire S, Ahn S, Lefkowitz R, Shenoy S . Beta-arrestins and cell signaling. Annu Rev Physiol. 2007; 69:483-510. DOI: 10.1146/annurev.physiol.69.022405.154749. View

11.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

12.

Suzuki M, Narita M, Niikura K, Nakamura A, Miyatake M, Yajima Y . mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine. Neuroscience. 2006; 138(2):609-19. DOI: 10.1016/j.neuroscience.2005.11.046. View

13.

Johnson E, Oldfield S, Braksator E, Gonzalez-Cuello A, Couch D, Hall K . Agonist-selective mechanisms of mu-opioid receptor desensitization in human embryonic kidney 293 cells. Mol Pharmacol. 2006; 70(2):676-85. DOI: 10.1124/mol.106.022376. View

14.

Liao D, Grigoriants O, Wang W, Wiens K, Loh H, Law P . Distinct effects of individual opioids on the morphology of spines depend upon the internalization of mu opioid receptors. Mol Cell Neurosci. 2007; 35(3):456-69. PMC: 1931568. DOI: 10.1016/j.mcn.2007.04.007. View

15.

Cho J, Tsai M . The role of BETA2/NeuroD1 in the development of the nervous system. Mol Neurobiol. 2004; 30(1):35-47. DOI: 10.1385/MN:30:1:035. View

16.

Grewal S, York R, Stork P . Extracellular-signal-regulated kinase signalling in neurons. Curr Opin Neurobiol. 1999; 9(5):544-53. DOI: 10.1016/S0959-4388(99)00010-0. View

17.

Violin J, Lefkowitz R . Beta-arrestin-biased ligands at seven-transmembrane receptors. Trends Pharmacol Sci. 2007; 28(8):416-22. DOI: 10.1016/j.tips.2007.06.006. View

18.

Zheng H, Chu J, Qiu Y, Loh H, Law P . Agonist-selective signaling is determined by the receptor location within the membrane domains. Proc Natl Acad Sci U S A. 2008; 105(27):9421-6. PMC: 2453714. DOI: 10.1073/pnas.0802253105. View

19.

Rodriguez A, Griffiths-Jones S, Ashurst J, Bradley A . Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004; 14(10A):1902-10. PMC: 524413. DOI: 10.1101/gr.2722704. View

20.

Zeng Y . Principles of micro-RNA production and maturation. Oncogene. 2006; 25(46):6156-62. DOI: 10.1038/sj.onc.1209908. View